Literature DB >> 17307368

Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice.

Roberto M Saraiva1, Khalid M Minhas, Meizi Zheng, Eleanor Pitz, Adriana Treuer, Daniel Gonzalez, Karl H Schuleri, Koenraad M Vandegaer, Lili A Barouch, Joshua M Hare.   

Abstract

Disruption of leptin signaling in the heart may contribute to obesity-related cardiac disease, as leptin deficient (oblob) mice display cardiac hypertrophy, increased cardiac apoptosis and reduced survival. Since leptin maintains a tonic level of neuronal nitric oxide synthase (NOS1) expression in the brain, we hypothesized that leptin deficiency would decrease NOS1 cardiac expression, in turn activating xanthine oxidoreductase (XOR) and creating nitroso-redox imbalance. We studied 2- to 6-month-old oblob (n=26) and C57Bl/6 controls (n=27). Cardiac NOS1 protein abundance (P<0.01) and mRNA expression (P=0.03) were reduced in oblob (n=10 and 6, respectively), while NOS3 protein abundance and mRNA expression were unaltered. Importantly, cardiac NOS1 protein abundance was restored towards normal in oblob mice after leptin treatment (n=3; P<0.05 vs leptin untreated oblob mice). NO metabolite (nitrite and nitrate) production within the myocardium was also reduced in oblob mice (n=5; P=0.02). Furthermore, oxidative stress was increased in oblob mice as GSH/GSSG ratio was decreased (n=4; P=0.02). Whereas XOR activity measured by Amplex Red fluorescence was increased (n=8; P=0.04), XOR and NADPH oxidase subunits protein abundance were not changed in oblob mice (n=6). Leptin deficiency did not disrupt NOS1 subcellular localization, as NOS1 co-localized with ryanodine receptor but not with caveolin-3. In conclusion, leptin deficiency is linked to decreased cardiac expression of NOS1 and NO production, with a concomitant increase in XOR activity and oxidative stress, resulting in nitroso-redox imbalance. These data offer novel insights into potential mechanisms of myocardial dysfunction in obesity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17307368      PMCID: PMC2754218          DOI: 10.1016/j.niox.2006.12.001

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  47 in total

Review 1.  Obesity, heart failure and sudden death.

Authors:  F Contaldo; F Pasanisi; C Finelli; G de Simone
Journal:  Nutr Metab Cardiovasc Dis       Date:  2002-08       Impact factor: 4.222

2.  Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.

Authors:  Lili A Barouch; Robert W Harrison; Michel W Skaf; Gisele O Rosas; Thomas P Cappola; Zoulficar A Kobeissi; Ion A Hobai; Christopher A Lemmon; Arthur L Burnett; Brian O'Rourke; E Rene Rodriguez; Paul L Huang; João A C Lima; Dan E Berkowitz; Joshua M Hare
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

3.  The disease burden associated with overweight and obesity.

Authors:  A Must; J Spadano; E H Coakley; A E Field; G Colditz; W H Dietz
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

4.  Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.

Authors:  M Scherrer-Crosbie; R Ullrich; K D Bloch; H Nakajima; B Nasseri; H T Aretz; M L Lindsey; A C Vançon; P L Huang; R T Lee; W M Zapol; M H Picard
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

5.  Leptin is associated with increased risk of myocardial infarction.

Authors:  S Söderberg; B Ahrén; J H Jansson; O Johnson; G Hallmans; K Asplund; T Olsson
Journal:  J Intern Med       Date:  1999-10       Impact factor: 8.989

6.  Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension: role of Jak/STAT pathway.

Authors:  Loren E Wold; David P Relling; Jinhong Duan; Faye L Norby; Jun Ren
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

7.  Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO.

Authors:  M W Nickola; L E Wold; P B Colligan; G J Wang; W K Samson; J Ren
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

Review 8.  Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research.

Authors:  Dimitrios Tsikas
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-09-06       Impact factor: 3.205

9.  Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A.

Authors:  S I Yamagishi ; D Edelstein; X L Du; Y Kaneda; M Guzmán; M Brownlee
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

10.  Leptin affects adenylate cyclase activity in H9c2 cardiac cell line: effects of short- and long-term exposure.

Authors:  Gennaro Illiano; Silvio Naviglio; Mario Pagano; Annamaria Spina; Emilio Chiosi; Michelangela Barbieri; Giuseppe Paolisso
Journal:  Am J Hypertens       Date:  2002-07       Impact factor: 2.689

View more
  29 in total

1.  Role of nitric oxide (NO) metabolism and inflammatory mediators in childhood obesity.

Authors:  András Hrabák; László Derzbach; Ildikó Csuka; Tamás Bajor; Anna Körner
Journal:  Inflamm Res       Date:  2011-08-27       Impact factor: 4.575

Review 2.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

3.  Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction.

Authors:  Zhongbing Lu; Xin Xu; Xinli Hu; Guangshuo Zhu; Ping Zhang; Elza D van Deel; Joel P French; John T Fassett; Tim D Oury; Robert J Bache; Yingjie Chen
Journal:  Hypertension       Date:  2007-11-12       Impact factor: 10.190

Review 4.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Aberrant S-nitrosylation mediates calcium-triggered ventricular arrhythmia in the intact heart.

Authors:  Michael J Cutler; Bradley N Plummer; Xiaoping Wan; Qi-An Sun; Douglas Hess; Haiyan Liu; Isabelle Deschenes; David S Rosenbaum; Jonathan S Stamler; Kenneth R Laurita
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

6.  Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalance.

Authors:  Raul A Dulce; Omer Yiginer; Daniel R Gonzalez; Garrett Goss; Ning Feng; Meizi Zheng; Joshua M Hare
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

Review 7.  The complexities of diabetic cardiomyopathy: lessons from patients and animal models.

Authors:  Romain Harmancey; Heinrich Taegtmeyer
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

8.  Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes.

Authors:  Daniel R Gonzalez; Farideh Beigi; Adriana V Treuer; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

9.  Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice.

Authors:  Sang Jun Lee; Garrett Heinrich; Larisa Fedorova; Qusai Y Al-Share; Kelly J Ledford; Mats A Fernstrom; Marcia F McInerney; Sandra K Erickson; Cara Gatto-Weis; Sonia M Najjar
Journal:  Gastroenterology       Date:  2008-08-20       Impact factor: 22.682

10.  NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy.

Authors:  Daniel R Gonzalez; Adriana V Treuer; Guillaume Lamirault; Vera Mayo; Yenong Cao; Raul A Dulce; Joshua M Hare
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.